Skip to main content
Annals of Intensive Care
Download PDF

Risk factors for bleeding complications in patients undergoing extracorporeal cardiopulmonary resuscitation following out-of-hospital cardiac arrest: a secondary analysis of the SAVE-J II study

Annals of Intensive Care volume 14, Article number: 16 (2024) Cite this article

Abstract

Background

Bleeding is the most common complication in out-of-hospital cardiac arrest (OHCA) patients receiving extracorporeal cardiopulmonary resuscitation (ECPR). No studies comprehensively described the incidence rate, timing of onset, risk factors, and treatment of bleeding complications in OHCA patients receiving ECPR in a multicenter setting with a large database. This study aimed to analyze the risk factors of bleeding during the first day of admission and to comprehensively describe details of bleeding during hospitalization in patients with OHCA receiving ECPR in the SAVE-J II study database.

Methods

This study was a secondary analysis of the SAVE-J II study, which is a multicenter retrospective registry study from 36 participating institutions in Japan in 2013–2018. Adult OHCA patients who received ECPR were included. The primary outcome was the risk factor of bleeding complications during the first day of admission. The secondary outcomes were the details of bleeding complications and clinical outcomes.

Results

A total of 1,632 patients were included. Among these, 361 patients (22.1%) had bleeding complications during hospital stay, which most commonly occurred in cannulation sites (14.3%), followed by bleeding in the retroperitoneum (2.8%), gastrointestinal tract (2.2%), upper airway (1.2%), and mediastinum (1.1%). These bleeding complications developed within two days of admission, and 21.9% of patients required interventional radiology (IVR) or/and surgical interventions for hemostasis. The survival rate at discharge of the bleeding group was 27.4%, and the rate of favorable neurological outcome at discharge was 14.1%. Multivariable logistic regression analysis showed that the platelet count (< 10 × 104/μL vs > 10 × 104/μL) was significantly associated with bleeding complications during the first day of admission (adjusted odds ratio [OR]: 1.865 [1.252–2.777], p = 0.002).

Conclusions

In a large ECPR registry database in Japan, up to 22.1% of patients experienced bleeding complications requiring blood transfusion, IVR, or surgical intervention for hemostasis. The initial platelet count was a significant risk factor of early bleeding complications. It is necessary to lower the occurrence of bleeding complications from ECPR, and this study provided an additional standard value for future studies to improve its safety.

Background

Although the efficacy of extracorporeal cardiopulmonary resuscitation (ECPR) in patients with out-of-hospital cardiac arrest (OHCA) was recently examined [1,2,3], its safety should also be considered. Despite the great development of ECPR, bleeding is still its most common complication in OHCA patients [4,5,6,7,8,9,10,11,12]. Belohlavek et al. reported that there were major bleeding occurred in 36 patients (31%) treated with an invasive strategy including ECPR, and 10 patients (15%) received conventional cardiopulmonary resuscitation, and fatal bleeding occurred in 4 patients (11%) and non (0%), respectively [1]. In the Chinese ECMO registry that includes ECPR, patients with any bleeding complications had a significantly higher in-hospital mortality rate than those without [12].

Several studies discussed the clinical characteristics and risk factors of bleeding complications in a small number of OHCA patients who underwent ECPR [4,5,6,7,8,9,10, 13]. Parameters related to bleeding complications, such as anticoagulation therapy, blood transfusion status, and laboratory data, were also not discussed [12]. Thus, no studies comprehensively described the incidence rate, timing of onset, risk factors, and treatment of bleeding complications in OHCA patients who received ECPR in a multicenter setting with a large database.

Therefore, this study aimed to examine the risk factors and details of bleeding complications in patients with OHCA who received ECPR using a dataset from 36 institutions in Japan.

Methods

SAVE-J II study

The SAVE-J II study was a multicenter retrospective registry study conducted in Japan, with 36 participating institutions [14]. The study aimed to investigate the outcomes of OHCA patients who received ECPR [14]. The study was registered at the University Hospital Medical Information Network Clinical Trials Registry and the Japanese Clinical Trial Registry (registration number: UMIN000036490) and approved by the institutional review board of Kagawa University (approval number: 2018–110) and each participating institution, including St. Luke’s International Hospital (approval number: 18-R188).

Study design and participants

This study performed a secondary analysis of the SAVE-J II study [14], which included patients aged 18 years or older who presented with OHCA, were admitted to the emergency department between January 1, 2013, and December 31, 2018, and received ECPR (resuscitation for cardiac arrest with venoarterial extracorporeal membrane oxygenation [VA-ECMO]). The exclusion criteria were as follows: patients who received VA-ECMO after intensive care unit (ICU) admission, patients who were withdrawn after cannulation due to the return of spontaneous circulation (ROSC), patients with external causes of cardiac arrest, such as acute aortic dissection/aortic aneurysm, hypothermia, primary cerebral disorders, infection, drug intoxication, trauma, suffocation, and drowning, patients who achieved ROSC at hospital arrival and ECMO initiation, patients who transferred from other hospitals, patients with unknown outcomes and cannula insertion failure, and patients without records of bleeding complications. This secondary analysis was conducted with the approval of the institutional review board of St. Luke's International Hospital (approval number: 21-R135), and the requirement for informed consent was waived. All procedures were performed in accordance with the ethical standards of the review board of St. Luke's International Hospital on human experimentation and with the Helsinki Declaration of 1975.

Data collection

The following information of ECPR patients in SAVE-J II was collected: age, sex, comorbidities, antiplatelet/anticoagulant medications taken regularly prior to hospital admission, location of cardiac arrest, occurrence of witnessed cardiac arrest and bystander cardiopulmonary resuscitation (CPR), initial cardiac rhythm at the scene and prior to ECMO initiation, time course, laboratory data obtained upon arrival, place of ECMO cannulation, volume of blood transfusion within 48 h after ICU admission, coronary angiography (CAG), percutaneous catheter intervention (PCI), interventional radiology (IVR), surgical intervention for hemostasis, etiology of cardiac arrest, length of ICU stay, length of hospital stay, in-hospital mortality, neurological outcomes, and occurrence, and site of bleeding complications.

Definitions

The time from call ambulance to arrival was defined as time from the call to emergency medical services until hospital arrival. The estimated low flow time was defined as the time from cardiac arrest to the establishment of ECMO if the location of cardiac arrest was in an ambulance and the time from calling an ambulance to the establishment of ECMO if cardiac arrest happened in other location. Cardiac arrest was either due to cardiac causes like acute coronary syndrome, arrhythmia, myopathy, and myocarditis, or non-cardiac causes like pulmonary embolism.

Bleeding complications

First, bleeding complications during hospitalization, not limited to the first 48 h after admission in this registry, were assessed. Bleeding complications were defined as cases requiring blood transfusion, IVR, or surgical hemostasis, except for cases of cerebral hemorrhage confirmed by CT scan. Bleeding sites were cannula sites, retroperitoneum, puncture sites (excluding ECMO cannulation site), the brain, upper airway, chest (including mediastinal bleeding, hemothorax, pulmonary hemorrhage, etc.), abdomen (including gastrointestinal tract bleeding, liver, spleen, and abdominal cavity), and other sites. Blood transfusions apparently required for the consumption through ECMO device were not defined (included) as bleeding complications.

Prehospital resuscitation efforts by emergency medical service personnel and the details of ECPR implementation in Japan

A previous study showed the details of the emergency medical service (EMS) system in Japan [15]. Prehospital termination of resuscitation by EMS personnel is not allowed unless patients have evident signs of death (i.e., rigor mortis and postmortem lividity). Thus, the EMS personnel in Japan must perform resuscitation and transport patients with OHCA to the hospital with continuous resuscitation efforts until the achievement of ROSC or upon hospital arrival. As for the details of ECPR initiation, a previous study reported differences in ECPR practice in patients with OHCA from the emergency room (ER) to the ICU [16]. In two-thirds of institutions, emergency physicians perform cannulation. The catheterization room was the most common location of cannulation (48.6%), followed by the ER (31.4%). Vascular access was obtained via percutaneous through ultrasonography (47.2%), followed by percutaneous without ultrasonography (44.4%) [16].

Outcome measures

The primary outcome was the risk factor of bleeding complications during the first day of admission. The secondary outcomes were the details of bleeding complications, such as incidence rate, timing of onset, treatment requiring blood transfusion, IVR, or/and surgical interventions for hemostasis in patients undergoing ECPR. Moreover, clinical outcomes, such as survival at hospital discharge, neurological outcomes, and length of ICU stay were evaluated.

Statistical analysis

Continuous variables are presented as medians with interquartile ranges (IQRs), while categorical variables are presented as numbers and percentages (%). The hazards of bleeding were calculated as proportions of patients with bleeding complications among those who were alive initially. Mann–Whitney-Wilcoxon test and chi-squared test were used to compare continuous and categorical variables between the two groups, respectively. The mixed-effects logistic regression model was used to evaluate the influence of multiple predictors on the binary outcome. This model includes both observed covariates (fixed effects) and inter-group variability (random effects). In particular, the random effect was incorporated to account for variations in center effect across different facilities. The multivariate analysis was adjusted for age, comorbidities, medications, estimated low flow time, hemoglobin, platelets, fibrinogen, ECMO cannulation place, and each institution, which were considered as clinically relevant and previously reported as risk factors for bleeding complications [10, 17,18,19,20,21]. To assess the robustness of our risk factor study, additional analyses were conducted with composite outcome including bleeding complication and death during the first day of admission, and with competing risk analysis using Fine-Gray model accounting for early mortality during the first week of admission. The odds ratios (ORs) with 95% confidence intervals were calculated. P-values of < 0.05 were considered statistically significant. All statistical analyses were conducted using JMP Pro 17.0.0 (SAS, the USA) and R software version 4.1.1 (R Foundation for Statistical Computing, Vienna, Austria). Missing data were not replaced or estimated.

Results

A patient selection flow chart is shown in Fig. 1. Of the 2,157 adult patients with OHCA who received ECPR in SAVE-J II, 1,632 patients were included in this study, of which 361 patients (22.1%) developed bleeding complications (bleeding group) during hospitalization, while 1,271 (77.9%) did not (non-bleeding group).

Fig. 1
figure 1

Patient selection flow chart. ECPR, extracorporeal cardiopulmonary resuscitation; VA-ECMO, venoarterial extracorporeal membrane oxygenation; ICU, intensive care unit; ROSC, return of spontaneous circulation

Full size image

Characteristics of eligible patients

The study population consisted of 1,632 patients, with a median age of 60 years (IQR, 49–68), and 84.7% were men. Among them, 16.1% were regularly taking antiplatelet or anticoagulant medications, while 2.2% were taking both regularly. The median time from call ambulance to arrival was 32 min (IQR, 26–39), and the estimated low flow time was 55 min (IQR, 45–66). Cannulation was performed in an ER, catheter laboratory, and other places in 64.0%, 35.8%, and 0.2%, respectively. On arrival, the median hemoglobin level was 12.9 g/dL (IQR, 11.0–14.6), platelet count was 14.7 × 104/µL (IQR, 10.9–19.0), fibrinogen level was 215 mg/dL (IQR, 164–277), and D-dimer level was 14.3 μg/mL (IQR, 5.7–31.4). The etiology of cardiac arrest was cardiogenic (86.4%), non-cardiogenic (6.5%), and unknown (7.1%). The median length of ICU stay was 3 (IQR: 1–10) days. The rates of survival discharge and favorable neurological outcome upon hospital discharge were 27.4% and 14.1%, respectively. In a univariate analysis of the bleeding and non-bleeding groups during hospitalization, significant differences were observed in terms of age, time from call ambulance to arrival, platelet count upon arrival, rhythm before ECMO initiation, ECMO cannulation place, red blood cell administration, blood product transfusion volume from arrival to 48 h after ICU admission, CAG, PCI, and etiology of cardiac arrest. The non-bleeding group had a significantly longer length of ICU and hospital stay than the bleeding group (median: 7 vs. 2 days, p < 0.001; 9 vs. 3 days, p < 0.001, respectively). The non-bleeding group had a higher survival at discharge than the bleeding group (34.9% vs 25.3%, p < 0.001). No significant difference was observed in terms of the favorable neurological outcomes at discharge from the hospital (13.9% vs 14.2%, p = 0.881) (Table 1).

Table 1 Characteristics and comparisons between patients with and without bleeding complications during hospitalizationa
Full size table

Incidence rate of bleeding complications during hospitalization

The total incidence of bleeding complications during hospital stay was 22.1% (431/361 patients). The most common bleeding sites were ECMO cannulation sites (14.3%), followed by the retroperitoneum (2.8%), gastrointestinal tract (2.2%), upper airway (1.2%), and mediastinum (1.1%) (Fig. 2).

Fig. 2
figure 2

Bleeding complications in each organ. N = numbers

Full size image

Timing of onset bleeding complications during hospitalization

Changes in seven-day hazards of bleeding complications for each bleeding site are shown in Fig. 3. The highest incidence of bleeding occurred on the first day, except for cerebral hemorrhage. After the fourth day, the hazard for each bleeding site progressively decreased to < 0.5%, but only ECMO cannulation site bleeding slightly increased on the fifth day.

Fig. 3
figure 3

Hazard of bleeding complications. ECMO: extracorporeal membrane oxygenation. The hazards of bleeding complications at major bleeding sites were calculated as proportions of patients with bleeding complications on the day among those who were alive at the beginning of the day

Full size image

Risk factors for bleeding complications during the first day of admission

In a univariate analysis of the bleeding and non-bleeding groups during the first day of admission, significant differences were observed in terms of platelet counts and ECMO cannulation place, as shown in Additional file 1: Table S1. The mixed-effects logistic regression analysis showed a significant difference in terms of platelet count (< 10 × 104/μL; adjusted OR: 1.865 [1.252–2.777], p = 0.002). (Table 2). By using composite outcome including bleeding complication and death, initial platelet count remained significant difference, and the result of the competing risk analysis accounting for early death was also determined the significant difference of initial platelet count (Sub-hazard ratio: 1.72[1.33ー2.22], p < 0.001). These results are shown in Additional file 1: Table S2, S3 and Figure S1.

Table 2 Multivariable analysis of factors associated with bleeding complications within the first day of admission among out-of-hospital cardiac arrest patients who received ECPR
Full size table

Transfusions and interventions required for bleeding complications within the first 48 h of admission

About 64.3% received red blood cell transfusions from hospital arrival until 48 h after ICU admission (Table 1). The median transfusion volumes of red blood cells, fresh frozen plasma, and platelets were 4 units (IQR, 0–10), 4 units (IQR, 0–10), and 0 units (IQR, 0–0), respectively (Table 1). The median total blood transfusion volume per bleeding site was the highest for liver bleeding at 73 units (IQR, 29.5–136), followed by intraperitoneal bleeding at 41 units (IQR, 14–54) and hemothorax at 40 units (IQR, 22–96). For hemostasis, IVR was required in 25 patients (1.2%), 60 patients (3.3%) required surgical interventions, and 6 patients (0.4%) required both. Among 361 patients with bleeding complications during their hospital stay, 21.9% required IVR or/and surgical interventions for hemostasis. Among the 25 patients who required IVR, 8 (32.0%) had mediastinal bleeding, 7 (28.0%) had liver bleeding, 3 (12.0%) had retroperitoneal bleeding, and 3 (12.0%) had hemothorax. Of the 60 patients who required surgical hemostasis, cannulation site bleeding occurred most frequently (41 patients, 68.3%), followed by liver bleeding in 6 patients (10.0%) and mediastinal bleeding in 4 patients (6.7%) (Table 3).

Table 3 Blood transfusions and interventions required for bleeding complications within the first 48 h because information on the exact volume of blood transfused was only obtained during this time in this registry
Full size table

Discussion

This study described the incidence rate, timing of onset and treatment of each bleeding site, and risk factors associated with bleeding complications occurring within the first day of admission in OHCA patients who received ECPR.

Bleeding is the most common complication among ECPR patients [22]. However, due to the limited sample size and single-center nature of many studies, the reported incidence rates varied widely (8–70%) [1, 2, 4,5,6,7,8,9,10, 13, 23,24,25]. Its incidence rate among 1,632 patients (median age 60, male 84.7%, antiplatelet or/and anticoagulant medication 15.8%, cardiac etiology 86.4%, PCI 46.5%, survival to hospital discharge 27.4%) with OHCA who received ECPR was 22.1%, and ECMO cannula site bleeding had the highest incidence (14.3%), followed by retroperitoneal bleeding (2.8%). In general, ECPR is associated with a higher risk of bleeding compared with cardiac ECMO due to CPR-related injuries and technical difficulties in puncturing due to the absence of a palpable pulse [22]. Aubron et al. reported bleeding events in 80% of patients with VA-ECMO, which are based on the bleeding definition of the Extracorporeal Life Support Organization (ELSO). The value is significantly higher than that of our findings. However, it is important to consider that the shorter duration of ECMO support in patients undergoing ECPR could reduce the recorded incidence of bleeding caused by early mortality before the bleeding complications are detected. Haas et al. reported a higher incidence rate of bleeding complications (31.3%) in 217 adult OHCA patients (median age 52, male 72.8%, percutaneous cannulation 71.0%, PCI 26.3%, survival hospital discharge 27.6%) who received ECPR using the ELSO registry data; ECMO cannulation site bleeding had the highest incidence (18.4%), followed by gastrointestinal bleeding (9.7%) compared with our study population. This variation can be affected by differences in patient characteristics and differences in the classification and definition of bleeding complications [26]. Haas et al. only assessed bleeding at sites recorded on the ELSO registry form, whereas the SAVE-J II registry examined all bleeding sites requiring blood transfusion; hence, our study provided a more detailed incidence rate of bleeding complications in ECPR patients using large real-world data. The classification and definition of bleeding complications should be standardized in future research and database registries to facilitate comparisons between different institutions and studies [12].

No studies reported the timing of onset of bleeding complications in OHCA patients who received ECPR. This study is the first to provide the daily hazards for each bleeding site. Except for cerebral bleeding, most bleeding from ECMO cannula site, the abdomen, chest, and retroperitoneum occurred within the first two days of ECMO initiation. CPR-related injuries were more apparent in ECPR patients than in conventional CPR patients possibly due to the extended survival with ECMO [27, 28], leading to increased hazards of bleeding within the first two days. Although the onset of bleeding from each site remained low (< 1.0%) beyond the third day, it was unclear whether these bleeding complications were exacerbations of an initial minor bleeding or new onset of major bleeding. Aubron et al. reported that the median onset of bleeding was on day 4, including those not limited to ECPR, with pre-bleeding APTT levels being associated with bleeding complications [29]. The bleeding beyond the third day may be related to prolonged APTT levels, with coagulopathy, and/or anticoagulation therapy after ECMO initiation. Our result provided additional knowledge for future studies.

In terms of the risk factors of bleeding during the first day of admission, initial platelet counts of < 10 × 104 /μL compared with > 10 × 104 /μL upon arrival were associated with an increased risk of bleeding. In addition, given the importance of early mortality in our study population, we conducted additional analyses by using a composite outcome that included both bleeding complications and death within the first day of hospitalization, and competing risk analysis accounting for early death within the first week of hospitalization. These results contribute to the robustness of the association between platelet count and bleeding complication. Only few studies examined the bleeding risk factors for ECPR, and in a retrospective analysis of Otani et al. on 102 OHCA patients who received ECPR, age, initial platelet count, and D-dimer levels were associated with major bleeding [10]. Hence, a lower initial platelet count may be a useful predictor of bleeding complications requiring blood transfusion. In patients with trauma who presented with ongoing major bleeding, the platelet threshold is 5.0 − 10 × 104/μL [30]. Thus, patients with ECPR may also require maintaining platelet counts above this value. Further investigations regarding the target populations, timing, and platelet counts during platelet transfusion should be performed.

Several studies reported that 40–80% of patients who undergo ECPR require blood transfusions [2, 28, 35, 36], which is comparable to the 64.3% observed in our present study. The most common bleeding sites requiring IVR were the mediastinum, followed by the liver, while the most common site requiring surgical intervention was ECMO cannula sites. Overall, 21.9% of bleeding patients required interventions. Although recent improvements in ECMO cannulation techniques using echo and X-ray fluoroscopy decreased the incidence of cannulation site bleeding [2, 9], it can still be life-threatening [37, 38]. If compression hemostasis is ineffective, a prompt surgical intervention is necessary for homeostasis. ELSO published an interim consensus statement on ECPR, which recommends that CT scan should be performed immediately in all ECPR cases [39]. IVR was also suggested for embolization of lacerations of the liver and spleen. Further studies are needed to examine optimal strategies and multidisciplinary treatment for patients with internal organ damage [40].

This retrospective observational study has several limitations. First, since this is a retrospective cohort study with chart review, it is possible that a greater number of patients had bleeding complications than what was actually recorded. Second, there were no standardized indications and subsequent management practices among participating institutions, which may have influenced the occurrence of bleeding complications. Third, due to the nature of the SAVE-J II registry data, information on the type of ECMO device, the ECMO cannulation method, use of anticoagulants and antiplatelet upon arrival, transfusions after the acute phase, other surgical interventions not aimed at hemostasis, or direct causes of death were not available. Fourth, since most patients had missing D-dimer values, the association with bleeding complications could not be analyzed. Fifth, as this study does not specify whether each bleeding event was caused by CPR, related procedures, or occurred spontaneously, specific measures to reduce bleeding complications could not be provided. Sixth, the rate of early mortality in this data set is high, which could be a competing risk for bleeding complication. Thus, the association between bleeding complications during hospitalization and clinical outcomes, such as survival and favorable neurological function, at hospital discharge was challenging to analyze.

Conclusions

We described the details of bleeding complications associated with ECPR in OHCA patients using large registry data from 36 institutions in Japan. Approximately 20% of OHCA patients who received ECPR developed bleeding complications, of which 20% required IVR and/or surgical intervention for hemostasis. Almost all bleeding complications developed within two days of admission, while bleeding at ECMO cannulation sites remained low beyond the third day. A decreased platelet count (< 10 × 104/μL compared with > 10 × 104/μL) upon arrival was an independent risk factor of bleeding complications within the first day of admission. It is necessary to improve its safety to decrease the occurrence of bleeding complications.

Availability of data and materials

The datasets used and analyzed during the current study are available from the authors upon reasonable request.

Abbreviations

CPR:

Cardiopulmonary resuscitation

ECPR:

Extracorporeal cardiopulmonary resuscitation

ELSO:

Extracorporeal Life Support Organization

EMS:

Emergency medical service

ICU:

Intensive care unit

IVR:

Interventional radiology

OHCA:

Of-hospital cardiac arrest

OR:

Odds ratio

PCI:

Percutaneous catheter intervention

ROSC:

Return of spontaneous circulation

References

  1. Belohlavek J, Smalcova J, Rob D, et al. Effect of Intra-arrest transport, extracorporeal cardiopulmonary resuscitation, and immediate invasive assessment and treatment on functional neurologic outcome in refractory out-of-hospital cardiac arrest. JAMA. 2022;327(8):737. https://doi.org/10.1001/jama.2022.1025.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Yannopoulos D, Bartos J, Raveendran G, et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial. Lancet. 2020;396(10265):1807–16. https://doi.org/10.1016/S0140-6736(20)32338-2.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Suverein MM, Delnoij TSR, Lorusso R, et al. Early extracorporeal CPR for refractory out-of-hospital cardiac arrest. N Engl J Med. 2023;388(4):299–309. https://doi.org/10.1056/nejmoa2204511.

    Article  PubMed  Google Scholar 

  4. Leick J, Liebetrau C, Szardien S, et al. Door-to-implantation time of extracorporeal life support systems predicts mortality in patients with out-of-hospital cardiac arrest. Clin Res Cardiol. 2013;102(9):661–9. https://doi.org/10.1007/s00392-013-0580-3.

    Article  PubMed  Google Scholar 

  5. Maekawa K, Tanno K, Hase M, Mori K, Asai Y. Extracorporeal cardiopulmonary resuscitation for patients with out-of-hospital cardiac arrest of cardiac origin: a propensity-matched study and predictor analysis. Crit Care Med. 2013;41(5):1186–96. https://doi.org/10.1097/CCM.0b013e31827ca4c8.

    Article  PubMed  Google Scholar 

  6. Kim SJ, Jung JS, Park JH, Park JS, Hong YS, Lee SW. An optimal transition time to extracorporeal cardiopulmonary resuscitation for predicting good neurological outcome in patients with out-of-hospital cardiac arrest: a propensity-matched study. Crit Care. 2014;18(5):1–15. https://doi.org/10.1186/s13054-014-0535-8.

    Article  Google Scholar 

  7. Lee JJ, Han SJ, Kim HS, et al. Out-of-hospital cardiac arrest patients treated with cardiopulmonary resuscitation using extracorporeal membrane oxygenation: focus on survival rate and neurologic outcome. Scand J Trauma Resusc Emerg Med. 2016;24(1):1–9. https://doi.org/10.1186/s13049-016-0266-8.

    Article  Google Scholar 

  8. Ha TS, Yang JH, Cho YH, et al. Clinical outcomes after rescue extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest. Emerg Med J. 2017;34(2):107–11. https://doi.org/10.1136/emermed-2015-204817.

    Article  PubMed  Google Scholar 

  9. Kashiura M, Sugiyama K, Tanabe T, Akashi A, Hamabe Y. Effect of ultrasonography and fluoroscopic guidance on the incidence of complications of cannulation in extracorporeal cardiopulmonary resuscitation in out-of-hospital cardiac arrest: a retrospective observational study. BMC Anesthesiol. 2017;17(1):1–7. https://doi.org/10.1186/s12871-016-0293-z.

    Article  Google Scholar 

  10. Otani T, Sawano H, Natsukawa T, et al. D-dimer predicts bleeding complication in out-of-hospital cardiac arrest resuscitated with ECMO. Am J Emerg Med. 2018;36(6):1003–8. https://doi.org/10.1016/j.ajem.2017.11.016.

    Article  PubMed  Google Scholar 

  11. Stub D, Bernard S, Pellegrino V, et al. Refractory cardiac arrest treated with mechanical CPR, hypothermia, ECMO and early reperfusion (the CHEER trial). Resuscitation. 2015;2015(86):88–94. https://doi.org/10.1016/j.resuscitation.2014.09.010.

    Article  Google Scholar 

  12. Li C, Cai T, Xie H, et al. Risk factors and outcomes for patients with bleeding complications receiving extracorporeal membrane oxygenation: An analysis of the Chinese Extracorporeal Life Support Registry. Artif Organs. 2022. https://doi.org/10.1111/aor.14321.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Nguyen ML, Gause E, Mills B, et al. Traumatic and hemorrhagic complications after extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest. Resuscitation. 2020;157:225–9. https://doi.org/10.1016/j.resuscitation.2020.09.035.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Inoue A, Hifumi T, Sakamoto T, et al. Extracorporeal cardiopulmonary resuscitation in adult patients with out-of-hospital cardiac arrest: a retrospective large cohort multicenter study in Japan. Crit Care. 2022;26(1):1–11. https://doi.org/10.1186/s13054-022-03998-y.

    Article  Google Scholar 

  15. Kitamura T, Kiyohara K, Sakai T, et al. Public-access defibrillation and out-of-hospital cardiac arrest in Japan. N Engl J Med. 2016;375(17):1649–59. https://doi.org/10.1056/nejmsa1600011.

    Article  PubMed  Google Scholar 

  16. Hifumi T, Inoue A, Takiguchi T, et al. Variability of extracorporeal cardiopulmonary resuscitation practice in patients with out-of-hospital cardiac arrest from the emergency department to intensive care unit in Japan. Acute Med Surg. 2021;8(1):1–10. https://doi.org/10.1002/ams2.647.

    Article  Google Scholar 

  17. Park IH, Yang JH, Jang WJ, et al. Clinical significance of low-flow time in patients undergoing extracorporeal cardiopulmonary resuscitation: results from the rescue registry. J Clin Med. 2020;9(11):1–12. https://doi.org/10.3390/jcm9113588.

    Article  CAS  Google Scholar 

  18. Schopka S, Philipp A, Lunz D, et al. Single-center experience with extracorporeal life support in 103 nonpostcardiotomy patients. Artif Organs. 2013;37(2):150–6. https://doi.org/10.1111/j.1525-1594.2012.01544.x.

    Article  PubMed  CAS  Google Scholar 

  19. Son AY, Khanh LN, Joung HS, et al. Limb ischemia and bleeding in patients requiring venoarterial extracorporeal membrane oxygenation. J Vasc Surg. 2021;73(2):593–600. https://doi.org/10.1016/j.jvs.2020.05.071.

    Article  PubMed  Google Scholar 

  20. Ellouze O, Abbad X, Constandache T, et al. Risk factors of bleeding in patients undergoing venoarterial extracorporeal membrane oxygenation. Ann Thorac Surg. 2021;111(2):623–8. https://doi.org/10.1016/j.athoracsur.2020.02.012.

    Article  PubMed  Google Scholar 

  21. Aubron C, DePuydt J, Belon F, et al. Predictive factors of bleeding events in adults undergoing extracorporeal membrane oxygenation. Ann Intensive Care. 2016;6:1. https://doi.org/10.1186/s13613-016-0196-7.

    Article  CAS  Google Scholar 

  22. Inoue A, Hifumi T, Sakamoto T, Kuroda Y. Extracorporeal cardiopulmonary resuscitation for out-of-hospital cardiac arrest in adult patients. J Am Heart Assoc. 2020;9(7):1–12. https://doi.org/10.1161/JAHA.119.015291.

    Article  Google Scholar 

  23. Gray BW, Haft JW, Hirsch JC, Annich GM, Hirschl RB, Bartlett RH. Extracorporeal life support: experience with 2,000 patients. ASAIO J. 2015;61(1):2–7. https://doi.org/10.1097/MAT.0000000000000150.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Dalia AA, Lu SY, Villavicencio M, et al. Extracorporeal cardiopulmonary resuscitation: outcomes and complications at a quaternary referral center. J Cardiothorac Vasc Anesth. 2020;34(5):1191–4. https://doi.org/10.1053/j.jvca.2019.12.016.

    Article  PubMed  Google Scholar 

  25. Lunz D, Calabrò L, Belliato M, et al. Extracorporeal membrane oxygenation for refractory cardiac arrest: a retrospective multicenter study. Intensive Care Med. 2020;46(5):973–82. https://doi.org/10.1007/s00134-020-05926-6.

    Article  PubMed  CAS  Google Scholar 

  26. Extracorporeal Life Support Organization (ELSO) ELSO Registry Data Definitions. Published 2018. https://www.elso.org/portals/0/files/elso registry data definitions 02_13_23.pdf

  27. Patricio D, Peluso L, Brasseur A, et al. Comparison of extracorporeal and conventional cardiopulmonary resuscitation: a retrospective propensity score matched study. Crit Care. 2019;23(1):1–10. https://doi.org/10.1186/s13054-019-2320-1.

    Article  Google Scholar 

  28. Bartos JA, Carlson K, Carlson C, et al. Surviving refractory out-of-hospital ventricular fibrillation cardiac arrest: critical care and extracorporeal membrane oxygenation management. Resuscitation. 2018;2018(132):47–55. https://doi.org/10.1016/j.resuscitation.2018.08.030.

    Article  Google Scholar 

  29. Aubron C, DePuydt J, Belon F, et al. Predictive factors of bleeding events in adults undergoing extracorporeal membrane oxygenation. Ann Intensive Care. 2016;6:1. https://doi.org/10.1186/s13613-016-0196-7.

    Article  CAS  Google Scholar 

  30. Rossaint R, Afshari A, Bouillon B, et al. The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition. Crit Care. 2023;27(1):1–45. doi: https://doi.org/10.1186/s13054-023-04327-7

  31. Zhang L, Liu W, Liu J, et al. Heparin loading dose in patients undergoing extracorporeal cardiopulmonary resuscitation. J Cardiothorac Vasc Anesth. 2023;000:1–7. https://doi.org/10.1053/j.jvca.2023.02.003.

    Article  CAS  Google Scholar 

  32. Iwashita Y, Yukimitsu M, Matsuduki M, Yamamoto A, Ishikura K, Imai H. Use of a fixed, body weight-unadjusted loading dose of unfractionated heparin for extracorporeal cardiopulmonary resuscitation. J Intensive Care. 2015;3(1):1–5. https://doi.org/10.1186/s40560-015-0098-z.

    Article  Google Scholar 

  33. Yannopoulos D, Bartos JA, Martin C, et al. Minnesota Resuscitation Consortium’s advanced perfusion and reperfusion cardiac life support strategy for out-of-hospital refractory ventricular fibrillation. J Am Heart Assoc. 2016;5(6):1–10. https://doi.org/10.1161/JAHA.116.003732.

    Article  Google Scholar 

  34. Lorusso R, Shekar K, MacLaren G, et al. ELSO interim guidelines for venoarterial extracorporeal membrane oxygenation in adult cardiac patients. ASAIO J. 2021;67(8):827–44. https://doi.org/10.1097/MAT.0000000000001510.

    Article  PubMed  Google Scholar 

  35. Dennis M, Zmudzki F, Burns B, et al. Cost effectiveness and quality of life analysis of extracorporeal cardiopulmonary resuscitation (ECPR) for refractory cardiac arrest. Resuscitation. 2019;2019(139):49–56. https://doi.org/10.1016/j.resuscitation.2019.03.021.

    Article  Google Scholar 

  36. Lamhaut L, Tea V, Raphalen JH, et al. Coronary lesions in refractory out of hospital cardiac arrest (OHCA) treated by extra corporeal pulmonary resuscitation (ECPR). Resuscitation. 2018;2018(126):154–9. https://doi.org/10.1016/j.resuscitation.2017.12.017.

    Article  Google Scholar 

  37. Nagao K, Hayashi N, Kanmatsuse K, et al. Cardiopulmonary cerebral resuscitation using emergency cardiopulmonary bypass, coronary reperfusion therapy and mild hypothermia in patients with cardiac arrest outside the hospital. J Am Coll Cardiol. 2000;36(3):776–83. https://doi.org/10.1016/S0735-1097(00)00779-8.

    Article  PubMed  CAS  Google Scholar 

  38. Tanaka D, Hirose H, Cavarocchi N, Entwistle JWC. The impact of vascular complications on survival of patients on venoarterial extracorporeal membrane oxygenation. Ann Thorac Surg. 2016;101(5):1729–34. https://doi.org/10.1016/j.athoracsur.2015.10.095.

    Article  PubMed  Google Scholar 

  39. Richardson AC, Tonna JE, Nanjayya V, et al. Extracorporeal Cardiopulmonary Resuscitation in Adults. Interim Guideline Consensus Statement from the Extracorporeal Life Support Organization. ASAIO Journal. 2021;1:221–8. https://doi.org/10.1097/MAT.0000000000001344.

    Article  Google Scholar 

  40. Lee JH, Ko RE, Park TK, Cho YH, Suh GY, Yang JH. Association between a multidisciplinary team approach and clinical outcomes in patients undergoing extracorporeal cardiopulmonary resuscitation in the emergency department. Kor Circ J. 2021;51(11):908–18. https://doi.org/10.4070/KCJ.2021.0167.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank all the members of the SAVE-J II study group who participated in this study: Hirotaka Sawano, M.D., Ph.D. (Osaka Saiseikai Senri Hospital), Yuko Egawa, M.D., Shunichi Kato, M.D. (Saitama Red Cross Hospital), Kazuhiro Sugiyama, M.D. (Tokyo Metropolitan Bokutoh Hospital), Naofumi Bunya, M.D., Takehiko Kasai, M.D. (Sapporo Medical University), Shinichi Ijuin, M.D., Shinichi Nakayama, M.D., Ph.D. (Hyogo Emergency Medical Center), Jun Kanda, M.D., Ph.D., Seiya Kanou, M.D. (Teikyo University Hospital), Toru Takiguchi, M.D., Shoji Yokobori, M.D., Ph.D. (Nippon Medical School), Hiroaki Takada, M.D., Kazushige Inoue, M.D. (National Hospital Organization Disaster Medical Center), Ichiro Takeuchi, M.D., Ph.D., Hiroshi Honzawa, M.D. (Yokohama City University Medical Center), Makoto Kobayashi, M.D., Ph.D., Tomohiro Hamagami, M.D. (Toyooka Public Hospital), Wataru Takayama, M.D., Yasuhiro Otomo, M.D., Ph.D. (Tokyo Medical and Dental University Hospital of Medicine), Kunihiko Maekawa, M.D. (Hokkaido University Hospital), Takafumi Shimizu, M.D., Satoshi Nara, M.D. (Teine Keijinkai Hospital), Michitaka Nasu, M.D., Kuniko Takahashi, M.D. (Urasoe General Hospital), Yoshihiro Hagiwara, M.D., M.P.H. (Imperial Foundation Saiseikai, Utsunomiya Hospital), Shigeki Kushimoto, M.D., Ph.D. (Tohoku University Graduate School of Medicine), Reo Fukuda, M.D. (Nippon Medical School Tama Nagayama Hospital), Takayuki Ogura, M.D., Ph.D. (Japan Red Cross Maebashi Hospital), Shin-ichiro Shiraishi, M.D. (Aizu Central Hospital), Ryosuke Zushi, M.D. (Osaka Mishima Emergency Critical Care Center), Norio Otani, M.D. (St. Luke’s International Hospital), Migaku Kikuchi, M.D., Ph.D. (Dokkyo Medical University), Kazuhiro Watanabe, M.D. (Nihon University Hospital), Takuo Nakagami, M.D. (Omihachiman Community Medical Center), Tomohisa Shoko, M.D., Ph.D. (Tokyo Women’s Medical University Medical Center East), Nobuya Kitamura, M.D., Ph.D. (Kimitsu Chuo Hospital), Takayuki Otani, M.D. (Hiroshima City Hiroshima Citizens Hospital), Yoshinori Matsuoka, M.D., Ph.D. (Kobe City Medical Center General Hospital), Makoto Aoki, M.D., Ph.D. (Gunma University Graduate School of Medicine), Masaaki Sakuraya, M.D., M.P.H. (JA Hiroshima General Hospital Hiroshima), Hideki Arimoto, M.D. (Osaka City General Hospital), Koichiro Homma, M.D., Ph.D. (Keio University School of Medicine), Hiromichi Naito, M.D., Ph.D. (Okayama University Hospital), Shunichiro Nakao, M.D., Ph.D. (Osaka University Graduate School of Medicine), Tomoya Okazaki, M.D., Ph.D. (Kagawa University Hospital), Yoshio Tahara, M.D., Ph.D. (National Cerebral and Cardiovascular Center), Hiroshi Okamoto, M.D, M.P.H. (St. Luke’s International Hospital), Jun Kunikata, M.D., Ph.D., Hideto Yokoi, M.D., Ph.D. (Kagawa University Hospital).

Funding

No funding was received for this study.

Author information

Authors and Affiliations

  1. Department of Emergency and Critical Care Medicine, St. Luke’s International Hospital, 9-1 Akashicho, Chuo-Ku, Tokyo, 104-8560, Japan

    Shutaro Isokawa, Toru Hifumi, Yu Watanabe, Katsuhiro Horie, Kijong Shin, Kasumi Shirasaki, Masahiro Goto & Norio Otani

  2. Department of Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan

    Keita Hirano

  3. Department of Emergency and Critical Care Medicine, Hyogo Emergency Medical Center, Kobe, Japan

    Akihiko Inoue

  4. Department of Emergency Medicine, Teikyo University School of Medicine, Tokyo, Japan

    Tetsuya Sakamoto

  5. Department of Emergency Medicine, Kagawa University School of Medicine, Kagawa, Japan

    Yasuhiro Kuroda

  6. Tama Family Clinic, Kanagawa, Japan

    Shiori Tomita

Authors
  1. Shutaro Isokawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toru Hifumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Keita Hirano
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yu Watanabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Katsuhiro Horie
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kijong Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kasumi Shirasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Masahiro Goto
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Akihiko Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Tetsuya Sakamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yasuhiro Kuroda
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Shiori Tomita
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Norio Otani
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. The SAVE-J II study group
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SI, TH, ST, and KH were involved in the study conception and design. SI and TH were responsible for data collection. SI, TH, ST, and KH performed the statistical analysis. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Toru Hifumi.

Ethics declarations

Ethics approval and consent to participate

This study was performed in accordance with the principles outlined in the Declaration of Helsinki and was approved by St. Luke’s International Hospital (approval number: 21-R135). The need for patient consent was waived.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Additional tables and figures.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Isokawa, S., Hifumi, T., Hirano, K. et al. Risk factors for bleeding complications in patients undergoing extracorporeal cardiopulmonary resuscitation following out-of-hospital cardiac arrest: a secondary analysis of the SAVE-J II study. Ann. Intensive Care 14, 16 (2024). https://doi.org/10.1186/s13613-024-01253-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13613-024-01253-x

Keywords